Alanquihan, Eufracia L.

HRN: 21-33-80  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/18/2022
05/24/2022
IV
4.5 Grams
Q8hrs
Empiric
Waiting Final Action 
05/20/2022
CEFTRIAXONE 1G (VIAL)
05/20/2022
05/27/2022
IV
2gm
OD
Urinalysis UTI
Waiting Final Action 
05/28/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/28/2022
06/03/2022
IVTT
4.5g
Q6
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: